Market Flash: iSHARES MSCI Indonesia Investable Market Index Fund (EIDO:US) PRICE: 28.530 USD Down -0.360 (-1.246%) >>> BI: Rupiah Melemah Akibat Kondisi Eropa >>> Pertemuan FED pertimbangkan langkah baru dorong ekonomi >>> KIJA akan Terbitkan MEN Valas USD150 Juta >>> PT Indika Energy Perusahaan Teladan Dunia 2011 >>> Govt Promises Revision of Cost Recovery Regulation >>> BPMigas Demands PGN to Pay US$6 per MMBTU >>> Jababeka to Raise US$150 Million from Debt Markets >>> SCG Chemicals buys Chandra Asri >>> Solusi Tunas eyes Rp380 bio IPO >>> SMR Utama scouts Rp300 bio IPO >>> Alam Sutera picks two bond arrangers >>> ASII Tetap Rajai Penjualan Mobil Agustus 2011 >>> Perusahaan Thailand kuasai Saham TPIA senilai Rp 3,76 Triliun >>> Agis Main ke Tambang, Sahamnya Masuk Dalam Pengawasan >>> ACES Mendekati The Northern Agar Mau Kurangi Kepemilikan >>> IHSG masih harus berjuang terus bertahan diatas MA200 >>> Melirik Peluang Akumulasi di Saham Perbankan >>> Analisa Saham BUMI: Kuat Bertahan & Berpeluang Kembali Uptrend >>> Analisa Saham JSMR: Bertahan Di Support, What Next? >>> INDF Tertahan Di Area Support Kuat, Berpeluang Rebound >>> ASII Break Minor Support, Sell on Strength >>> ADRO Membentuk Descending Wedges, Berpeluang Rebound Terbatas >>> Wall Street ends flat as early gains evaporate >>> Fed begins policy meeting, tiptoes toward easing >>> Fed meeting to help decide on long-term Treasuries >>> Greece Makes 'Good Progress' in Reform Talks: EC >>> China worried Europe debt crisis will hit trade >>> China could roll out 4.65tr yuan stimulus package >>> IMF sees Mideast stagnation >>> NYMEX-Crude ends higher at Oct contract expiry >>> Asian Crude Palm Oil Up On Technical Buying, Soyoil >>> Foreign net Sell - 61.785.746

Selasa, 29 Maret 2011

Kalbe Farma FY10 net income up 38.46% - Insider Stories

Indonesian giant pharmaceutical maker PT Kalbe Farma Tbk (KLBF) today reported a 38.46% increase in earning last year on the back of higher net sales.
In an official financial statement submitted to Indonesia Stock Exchange (IDX) today, Kalbe Farma posted IDR1.29 trillion net income last year from IDR929 billion in the previous year.

Income from operations increased 14.01% to IDR1.79 trillion from IDR1.57 trillion. However, Kalbe Farma's operating margin was flat at the level of 17%.
Gross profit rose 14.01% to IDR5.17 trillion from IDR4.51 trillion. Net sales increased 12.54% to IDR10.23 trillion from IDR9.09 trillion. The largest contributor for the net sales was distribution and packaging business with IDR3.21 trillion revenue.

Prescription pharmaceutical, consumer health, and nutritionals segments contributed revenue of IDR2.21 trillion, IDR1.73 trillion, and IDR1.94 trillion respectively.
PT Gira Sole Prima owns 10.17% shareholding in Kalbe Farma, PT Santa Seha Sanadi owns 9.62%, and PT Diptanala Bahana holds 9.49% stake.
PT Lucasta Murni Cemerlang, PT Ladang Ira Panen, PT Bina Artha Charisma, and public shareholders own 9.47%, 9.22%, 8.67%, and 43.36% respectively.
Posted by Saham Pilihan at 23.51

Tidak ada komentar:

Posting Komentar

Langganan: Posting Komentar (Atom)